Substituted sulfonamide compounds

US10179782B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10179782-B2
Application numberUS-201615042310-A
CountryUS
Kind codeB2
Filing dateFeb 12, 2016
Priority dateFeb 15, 2015
Publication dateJan 15, 2019
Grant dateJan 15, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention is concerned with the compounds of formula I: and salts thereof and other compounds of formulas II-IX as disclosed herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formulas I-IX as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain or asthma.

First claim

Opening claim text (preview).

We claim: 1. A compound selected from: or a pharmaceutically acceptable salt thereof. 2. The compound: or a pharmaceutically acceptable salt thereof. 3. The compound: or a pharmaceutically acceptable salt thereof. 4. The compound: or a pharmaceutically acceptable salt thereof. 5. The compound: or a pharmaceutically acceptable salt thereof. 6. The compound: or a pharmaceutically acceptable salt thereof. 7. The compound: or a pharmaceutically acceptable salt thereof. 8. The compound: or a pharmaceutically acceptable salt thereof. 9. The compound: or a pharmaceutically acceptable salt thereof. 10. A pharmaceutical composition, comprising a compound as described in claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Otologicals · CPC title

  • Centrally acting analgesics, e.g. opioids · CPC title

  • Drugs for disorders of the nervous system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10179782B2 cover?
The invention is concerned with the compounds of formula I: and salts thereof and other compounds of formulas II-IX as disclosed herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formulas I-IX as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating dise…
Who is the assignee on this patent?
Genentech Inc
What technology area does this patent fall under?
Primary CPC classification C07D417/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).